Central Line-associated Bloodstream Infection (CLABSI)

Bloodstream Infections in ICU Patiens with Central Lines. CDC Vital Signs™: www.cdc.gov/vitalsigns

Learn vital information about healthcare-associated infections.

Central line-associated bloodstream infections (CLABSIs) result in thousands of deaths each year and billions of dollars in added costs to the U.S. healthcare system, yet these infections are preventable. CDC is providing guidelines and tools to the healthcare community to help end CLABSIs.

Resources for Patients and Healthcare Providers


CDC, in collaboration with other organizations, has developed guidelines for the prevention of CLABSI and other types of healthcare-associated infections. Facilities can monitor the rates of CLABSI and assess the effectiveness of prevention efforts through CDC’s National Healthcare Safety Network (NHSN).

Monitoring CLABSIs

CDC’s National Healthcare Safety Network Patient Safety Component includes surveillance methods to identify and track device-associated infections, such as central-line associated bloodstream infections.

See the library of
Infection Control Guidelines